Internal Medicine, Endocrinology, Diabetes, & Metabolism · Goodyear, AZ
NPI
1528387834
Since 2010
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3000 N Litchfield Rd Ste 120
Goodyear, AZ, 85395
Phone (623) 398-2222
Groups this clinician bills Medicare through
Medicare paid, 2024
$218K
2,921 services
Medicare patients, 2024
721
Average age 73
Drug cost, 2024
$2.9M
5,252 prescriptions
Company payments, 2025
$1,609
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Suzi Kochar was code 99214 (office e&m - established), 1,192 times for 584 patients. In total Suzi Kochar billed 2,921 services in 21 codes, and Medicare paid $218K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,192 | 584 | $85.59 | $102K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 658 | 187 | $48.26 | $32K |
| 95251 Test - Miscellaneous | Office | 390 | 158 | $25.21 | $9,830 |
| 99215 Office E&M - Established | Office | 377 | 213 | $132.63 | $50K |
| 99204 Office E&M - New | Office | 105 | 105 | $111.90 | $12K |
| 99205 Office E&M - New | Office | 38 | 38 | $159.14 | $6,047 |
| 96372 Injection Administration | Office | 36 | 11 | $8.95 | $322 |
| 95250 Test - Miscellaneous | Office | 34 | 31 | $109.60 | $3,726 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 23 | 17 | $35.00 | $805 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 13 | 13 | $22.91 | $298 |
By year: 2022 $153K for 1,672 services; 2023 $171K for 2,060 services; 2024 $218K for 2,921 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 16 | 14 | $3.87 | $61.84 |
| 83036 Blood Count | 15 | 15 | $9.52 | $143 |
| 80061 Clinical Chemistry | 12 | 12 | $10.63 | $128 |
Medicare prescription drug claims, 2024
In 2024, the drug Suzi Kochar prescribed most often to Medicare patients was Levothyroxine Sodium, with 740 prescriptions and refills. In total Suzi Kochar wrote 5,252 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 740 | 2,089 | 233 | $7,013 |
| Metformin Hcl Er Metformin Hcl | 266 | 752 | 87 | $2,163 |
| Mounjaro Tirzepatide | 185 | 220 | 41 | $229K |
| Metformin Hcl Generic | 182 | 516 | 66 | $1,547 |
| Ozempic Semaglutide | 180 | 299 | 49 | $288K |
| Jardiance Empagliflozin | 166 | 297 | 41 | $170K |
| Atorvastatin Calcium Generic | 123 | 359 | 45 | $1,018 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 123 | 318 | 54 | $16K |
| Rosuvastatin Calcium Generic | 120 | 318 | 43 | $1,531 |
| Gabapentin Generic | 119 | 272 | 35 | $2,244 |
| Alendronate Sodium Generic | 104 | 261 | 34 | $769 |
| Trulicity Dulaglutide | 98 | 141 | 32 | $131K |
| Synthroid Levothyroxine Sodium | 94 | 259 | 26 | $10K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 84 | 199 | 40 | $14K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 83 | 151 | 18 | $100K |
Brand drugs: 2,148 claims; generic drugs: 2,784 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Suzi Kochar $1,609 ($1,609 in general payments such as food, travel and fees) from 27 companies. The largest payer was Novo Nordisk Inc with $372.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 22 | $372 |
| Corcept Therapeutics CORT | 8 | $250 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $113 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $105 |
| Medtronic, Inc. MDT | 3 | $70.57 |
| Tandem Diabetes Care, Inc. TNDM | 5 | $70.55 |
| Amgen Inc. AMGN | 3 | $62.42 |
| Dexcom, Inc. DXCM | 3 | $56.26 |
| Averitas Pharma Inc. | 2 | $54.44 |
| Recordati_rare_diseases_inc. | 2 | $44.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.